Brian H Harcourt
Overview
Explore the profile of Brian H Harcourt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wielick C, Fries A, Dams L, Razafimahefa R, Heyne B, Harcourt B, et al.
Am J Infect Control
. 2022 Jul;
50(8):871-877.
PMID: 35908825
Background: In the context of the SARS-CoV-2 pandemic, reuse of personal protective equipment, specifically that of medical face coverings, has been recommended. The reuse of these typically single-use only items...
2.
Scholte F, Kabra K, Tritsch S, Montgomery J, Spiropoulou C, Mores C, et al.
Am J Infect Control
. 2022 Jul;
50(8):863-870.
PMID: 35908824
Background: The COVID-19 pandemic resulted in a worldwide shortage of N95 respirators, prompting the development of decontamination methods to enable limited reuse. Countries lacking reliable supply chains would also benefit...
3.
Marasini D, Whaley M, Jenkins L, Hu F, Jiang W, Topaz N, et al.
J Clin Microbiol
. 2022 Mar;
60(4):e0211121.
PMID: 35306833
To monitor the burden and changes in Haemophilus influenzae (Hi) disease, direct real-time PCR (drt-PCR) assays have been developed for Hi detection in monoplex form and its six serotypes in...
4.
Malenfant J, Joyce A, Choi M, Cossaboom C, Whitesell A, Harcourt B, et al.
MMWR Morb Mortal Wkly Rep
. 2022 Feb;
71(8):290-292.
PMID: 35202354
On December 19, 2019, the Food and Drug Administration (FDA) approved rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO, Merck) for the prevention of Ebola virus disease (EVD) caused by infection with Ebola virus,...
5.
Lendvay T, Chen J, Harcourt B, Scholte F, Lin Y, Kilinc-Balci F, et al.
Infect Control Hosp Epidemiol
. 2021 May;
43(7):876-885.
PMID: 34016200
Objective: The coronavirus disease 2019 (COVID-19) pandemic has resulted in shortages of personal protective equipment (PPE), underscoring the urgent need for simple, efficient, and inexpensive methods to decontaminate masks and...
6.
Choi M, Cossaboom C, Whitesell A, Dyal J, Joyce A, Morgan R, et al.
MMWR Recomm Rep
. 2021 Jan;
70(1):1-12.
PMID: 33417593
This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States. The vaccine contains rice-derived recombinant...
7.
Mayer O, Pfundt T, Fortenberry G, Harcourt B, Bower W
Disaster Med Public Health Prep
. 2020 Nov;
16(3):1279-1281.
PMID: 33148368
The need for increased testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has resulted in an increase of testing facilities outside...
8.
Blain A, Mandal S, Wu H, MacNeil J, Harrison L, Farley M, et al.
Open Forum Infect Dis
. 2016 Oct;
3(3):ofw152.
PMID: 27704009
In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and...
9.
Harcourt B, Anderson R, Wu H, Cohn A, MacNeil J, Taylor T, et al.
Open Forum Infect Dis
. 2015 Sep;
2(3):ofv117.
PMID: 26357666
Background. Antimicrobial treatment and chemoprophylaxis of patients and their close contacts is critical to reduce the morbidity and mortality and prevent secondary cases of meningococcal disease. Through the 1990's, the...
10.
Goldsmith C, Ksiazek T, Rollin P, Comer J, Nicholson W, Peret T, et al.
Emerg Infect Dis
. 2013 Jun;
19(6):886-91.
PMID: 23731788
During outbreaks of infectious diseases or in cases of severely ill patients, it is imperative to identify the causative agent. This report describes several events in which virus isolation and...